BPC-157: 92 Supplier Records, 4 Studies

ON THIS PAGE

1. Key findings
2. What each number actually counts
3. What the four records actually say
4. The one nobody has updated since 2015
5. Why the exact query matters
6. What the registry does not cover
7. Limitations and open questions
8. Sources

A supplier's product page and a clinical trial registry count two different things, and BPC-157 shows the gap between them about as starkly as any compound in this ledger. One number describes how many storefronts sell it. The other describes how many registered studies exist to have learned anything about it in the first place, and the second number is small enough to read in full.

What each number actually counts

92 of the 126 supplier records in this publication's ledger, read 2026-09-18, mention BPC-157 somewhere in the record. That count says nothing about safety, legitimacy, or market share. It says that when this publication's own dossiers were compiled, nearly three-quarters of the storefronts under observation carried the name somewhere on a page. ClinicalTrials.gov answers a different question. Queried the same day with the exact phrase a researcher would type, query.term=("BPC-157" OR "BPC 157" OR "Body Protection Compound"), the registry's own API returns a totalCount of 4. Whatever a reader concludes from 92 storefronts naming a compound, the registered study count sitting behind that name is not large, and it fits on one screen.

What the four records actually say

Read individually rather than as a single number, the four studies split unevenly. NCT07437547, Phase 2, status Recruiting, lists an estimated 120 participants and a start date of 2026-02-02; its own title names an acute hamstring muscle strain repair study. NCT07803250, Phase 1, has not yet begun: status Not Yet Recruiting, an estimated 30 participants, a registered start date of 2027-01-01, studying recovery after rotator cuff repair surgery. NCT07752381 is the only one marked Completed, with 40 actual participants and a start date of 2025-09-01, but it carries no phase designation in the registry at all, because its intervention is not the peptide itself: the study tested a branded dietary supplement gummy product containing BPC-157 among its listed ingredients, measuring inflammatory markers and self-reported recovery over eight weeks. A completed study and a Phase 2 drug trial are not the same kind of evidence, and the registry's own phase field is what marks the difference.

The one nobody has updated since 2015

The fourth record, NCT02637284, is a Phase 1 study of an oral BPC-157 tablet, registered with an estimated 42 participants and a start date of October 2015. Its status field reads Unknown, and its last update post date is 2015-12-22, nearly eleven years before this piece was written. Unknown is not this publication's characterization. It is ClinicalTrials.gov's own status category, applied when a study's last known status has passed its expected completion date without a sponsor confirming what happened next, and the registry preserves the last status it did receive, Active, Not Recruiting, rather than erasing the record. A study can sit in this category because it quietly finished and nobody filed the paperwork, because it stalled, or for reasons the registry does not capture. What the label does establish is that nothing about this study's current state is confirmed by the source a reader would otherwise cite for it.

Why the exact query matters

The same search, run without the quotation marks around each phrase, so the query matches the words compound and protection anywhere in a record rather than the exact three-word phrase, returns a totalCount of 19 for the identical date. That is not 19 additional BPC-157 studies. It is a broader match pulling in unrelated records that happen to contain those common words somewhere in an unrelated study's own title or description. A reader checking the four-study figure by typing a looser version of the same search will land on a number nearly five times larger and reasonably wonder which one is right. Both numbers came from the same registry on the same day. The quoted-phrase form is the one that answers the question this piece is asking.

What the registry does not cover

ClinicalTrials.gov counts studies that were registered with it, and registration is not universal. A laboratory study conducted entirely in vitro or in animals, a study run outside the jurisdictions that require registration, or research published directly in a journal without ever being entered into this particular registry, would not appear in this count no matter how substantial the underlying work. Four registered studies is not a claim that four studies are the only research that has ever touched this compound. It is a claim about what one specific, public, checkable registry shows on one specific day, which is a narrower and more useful thing to know than it might first sound.

Limitations and open questions

The 92-record ledger count is a count of this publication's own supplier dossiers that mention the compound's name, read 2026-09-18, not a measurement of the retail market as a whole and not an estimate of how many sellers exist beyond what this registry has observed. The four-study count and every field describing those studies were queried the same day directly from ClinicalTrials.gov's own API; a sponsor could update any of these records, including the eleven-year-old Unknown-status study, at any time after this piece was written. This piece takes no position on why a compound named this often in a retail ledger carries so few registered studies, or on whether the dietary-supplement study's findings say anything about the isolated peptide sold elsewhere in this ledger; it reports what the registry states and leaves the inference to the reader.

Ninety-two storefronts naming a compound is a fact about a market. Four registered studies, one of them a supplement product, is a fact about the evidence behind it, and the two numbers are answering different questions.

Sources

ClinicalTrials.gov API v2, queried 2026-09-18 with query.term=("BPC-157" OR "BPC 157" OR "Body Protection Compound"), for the totalCount of 4 and the individual study records NCT07437547, NCT07803250, NCT07752381, and NCT02637284; the same endpoint without quotation marks around each phrase, queried the same day, for the totalCount of 19. Supplier mention counts are this publication's own, from the dossier record in ledger/vendors.json, read 2026-09-18. Vendors are named here, never linked, per site policy.